Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05859217
Title A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) (Cabatezo-1)
Acronym Cabatezo-1
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jun Zhang, MD, PhD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
The University of Kansas Cancer Center - Westwood Kansas City Kansas 66205 United States Details
The University of Kansas Cancer Center - Indian Creek Overland Park Kansas 66211 United States Details
The University of Kansas Cancer Center - North Kansas City Missouri 64154 United States Details
The University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field